Physician
Sparks Family Hospital INC
Sparks Family Hospital INC was paid $875K by Medicaid between Dec 2020 and Dec 2024, across 51 billing codes. Its largest line is 99284, emergency room visit (serious) — 27% of everything it billed.
33Billing provider infoSPARKS FAMILY HOSPITAL INC
RENO, NV 89503
RENO, NV 89503
33aNPI1689229353assigned 08/08/2019
33bProvider typeEmergency Medicine Physician
28Total paid$875K
24GClaims38,710
24DCodes billed51
24AFirst – last monthDec 2020 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Nevada
Rank by total paid#18 of 216
Median peer was paid$63K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 141 | $398.51 | |
| 2021 | 11,372 | $187K | |
| 2022 | 10,940 | $244K | |
| 2023 | 10,101 | $259K | |
| 2024incomplete | 6,156 | $184K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 3,157 | 2,650 | $237K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 4,178 | 3,613 | $209K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 19% | 1,860 | 1,545 | $168K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.5% | 1,350 | 1,137 | $39K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.3% | 1,558 | 1,243 | $37K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.1% | 173 | 155 | $36K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.0% | 949 | 759 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 577 | 534 | $17K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.7% | 382 | 316 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.5% | 1,042 | 880 | $13K |
| 80053 | Comprehensive metabolic panel | 1.2% | 2,420 | 1,946 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 2,749 | 2,231 | $8K |
39 more codes
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,028 | $8K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 320 | $7K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,116 | $7K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 592 | $5K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,191 | $4K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 910 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 913 | $3K |
| 83690 | <1% | 1,147 | $3K | |
| 84484 | <1% | 603 | $2K | |
| 81001 | <1% | 1,334 | $2K | |
| 84703 | <1% | 473 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 334 | $2K |
| 87430 | <1% | 254 | $2K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,136 | $1K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 87 | $1K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 73 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 396 | $1K |
| 81025 | <1% | 448 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 109 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,394 | $1K |
| 87070 | <1% | 255 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 36 | $929.84 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 189 | $669.90 |
| 81003 | <1% | 491 | $421.52 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 459 | $400.59 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 19 | $355.95 |
| 83605 | <1% | 55 | $225.17 | |
| 87420 | <1% | 34 | $214.18 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 717 | $186.52 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 19 | $180.46 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 20 | $173.10 |
| 87077 | <1% | 14 | $139.63 | |
| 87186 | <1% | 27 | $98.81 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 16 | $76.87 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 34 | $48.63 |
| 85027 | <1% | 20 | $26.52 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 14 | $10.10 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 14 | $6.19 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 24 | $3.14 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFILTON, STEVE (EXECUTIVE VP-CFO)
Parent organizationSPARKS FAMILY HOSPITAL INC
| Provider | Location | Paid |
|---|---|---|
| District Hospital Partners L P | Washington, DC | $136.25M |
| Mcallen Hospitals L P | Edinburg, TX | $124.61M |
| Lancaster Hospital Corporation | Palmdale, CA | $108.63M |
| Universal Health Services of Rancho Springs INC | Murrieta, CA | $61.95M |
| Doctors Hospital of Laredo | Laredo, TX | $52.31M |
| Valley Hospital Medical Center | Las Vegas, NV | $47.03M |
| Northwest Texas Healthcare System INC | Amarillo, TX | $44.81M |
| Uhs of Bowling Green LLC | Bowling Green, KY | $41.21M |
| Uhs-Corona INC | Corona, CA | $35.18M |
| Spring Valley Medical Center | Las Vegas, NV | $33.58M |
| Aiken Regional Medical Centers LLC | Aiken, SC | $31.51M |
| Summerlin Hospital Medical Center L L C | Las Vegas, NV | $30.26M |
| Manatee Memorial Hospital L P | Bradenton, FL | $22.33M |
| Desert Springs Hospital | Las Vegas, NV | $22.29M |
| Fort Duncan Medical Center LP | Eagle Pass, TX | $15.80M |
| Psi Pride Institute INC | Eden Prairie, MN | $15.57M |
| Uhs of Fuller INC | S Attleboro, MA | $13.47M |
| Uhs of Texoma, INC | Denison, TX | $12.51M |
| Arbour INC | Boston, MA | $12.36M |
| Wellington Regional Medical Center LLC | Wellington, FL | $10.75M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.